课题基金 / 基金详情

MOLECULAR MECHANISMS OF APOLIPOPROTEIN B BIOGENESIS

MOLECULAR MECHANISMS OF APOLIPOPROTEIN B BIOGENESIS
载脂蛋白 B 生物发生的分子机制
批准号:
3364475
负责人:
VISHWANATH R LINGAPPA
金额:
$20.12万
依托单位国家:
美国
项目类别:
财政年份:
1991
资助国家:
美国
项目状态:
已结题
起止时间:
1991-01-01 至 1995-12-31

项目摘要

项目成果

VISHWANATH R LINGAPPA的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION: (Adapted from the Investigator's abstract): The investigators propose to investigate apolipoprotein B (apo B) biogenesis and apo B-containing lipoprotein particle formation. Apo B plays a major role in cholesterol transport. Hypercholesterolemia is a risk factor for atherosclerosis and coronary artery disease. Some patients with elevated serum cholesterol have a known defect in apo B structure. Many others have uncharacterized aberrations in metabolism of apo B containing lipoproteins, which may be related to defective assembly. An understanding of how these diverse lesions cause hyperlipoproteinemia will require detailed knowledge of the mechanism by which a normal lipoprotein particle is assembled and secreted. Yet, important features of lipoprotein particle assembly are poorly understood and not easily explained by current value of protein biogenesis and trafficking. Recently, the investigators have discovered unusual intermediates in the early events of apo B translocation across the endoplasmic reticulum membrane (see Preliminary Studies) by expression of cloned cDNAs encoding domains of apo B in both membrane-supplemented cell-free systems and in living cells. These intermediates will be characterized and related to stages in apo B-containing lipoprotein particle assembly, regulation and secretion. This analysis will be extended to later events in apo B biogenesis. Through these experiments a better understanding of apo B biogenesis and its relationship to lipoprotein particle formation will emerge. New insight into the mechanisms by which apo B may be post-translationally regulated under physiologic conditions and in hypercholesterolemic lipoprotein disorders of humans may follow.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Advancement of Novel Small Molecules for Treatment of Rabies
  • 批准号:
    8484791
  • 项目类别:
  • 资助金额:
    $11.1万
  • 财政年份:
    2012
  • 负责人:
    VISHWANATH R LINGAPPA
  • 依托单位:
Advancement of Novel Small Molecules for Treatment of Rabies
  • 批准号:
    8366564
  • 项目类别:
  • 资助金额:
    $33.07万
  • 财政年份:
    2012
  • 负责人:
    VISHWANATH R LINGAPPA
  • 依托单位:
STRUCTURAL STUDIES ON TRANSMEMBRANE PRION PROTEIN
PROTEIN PROTEIN INTERACTIONS DURING PRION PROTEIN BIOGENESIS
海外基金